Up-regulation of the amino acid transporter ATB0,+ (SLC6A14) in carcinoma of the cervix

Naren Gupta, Puttur D Prasad, Sharad A Ghamande, Pamela Moore Martin, Anne V. Herdman, Robert G. Martindale, Robert Podolsky, Sela Mager, Malliga E. Ganapathy, Vadivel Ganapathy

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Objective. ATB0,+ is an energy-coupled transporter for arginine and amino acid-based prodrugs. The objective of the study was to examine the expression of this transporter in cervical cancer. Methods. Specimens of normal ectocervical mucosa and cervical squamous cell carcinoma were used for determination of ATB0,+ mRNA levels by RT-PCR. A commercial dot blot of paired normal cervix and cervical cancer cDNA was also used to quantify ATB0,+ mRNA. ATB0,+ mRNA and protein in tissue sections were analyzed by in situ hybridization and immunohistochemistry/ immunofluorescence. Results. ATB0,+ mRNA increased 5.6-fold (P < 0.0004) in cervical cancer compared to normal cervix. This was associated with a parallel increase in ATB0,+ protein. Conclusions. Expression of ATB0,+ is minimal in normal cervix and is up-regulated in cervical cancer. The up-regulation of this highly concentrative transporter for arginine and prodrugs in cervical cancer has significant clinical and therapeutic relevance.

Original languageEnglish (US)
Pages (from-to)8-13
Number of pages6
JournalGynecologic Oncology
Volume100
Issue number1
DOIs
StatePublished - Jan 1 2006

Fingerprint

Amino Acid Transport Systems
Cervix Uteri
Uterine Cervical Neoplasms
Up-Regulation
Carcinoma
Messenger RNA
Prodrugs
Arginine
In Situ Hybridization
Fluorescent Antibody Technique
Squamous Cell Carcinoma
Mucous Membrane
Proteins
Complementary DNA
Immunohistochemistry
Polymerase Chain Reaction

Keywords

  • Amino acid transporter ATB
  • Arginine
  • Cervical cancer
  • Metastasis
  • Nitric oxide
  • Squamous cell carcinoma

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Up-regulation of the amino acid transporter ATB0,+ (SLC6A14) in carcinoma of the cervix. / Gupta, Naren; Prasad, Puttur D; Ghamande, Sharad A; Martin, Pamela Moore; Herdman, Anne V.; Martindale, Robert G.; Podolsky, Robert; Mager, Sela; Ganapathy, Malliga E.; Ganapathy, Vadivel.

In: Gynecologic Oncology, Vol. 100, No. 1, 01.01.2006, p. 8-13.

Research output: Contribution to journalArticle

Gupta, N, Prasad, PD, Ghamande, SA, Martin, PM, Herdman, AV, Martindale, RG, Podolsky, R, Mager, S, Ganapathy, ME & Ganapathy, V 2006, 'Up-regulation of the amino acid transporter ATB0,+ (SLC6A14) in carcinoma of the cervix', Gynecologic Oncology, vol. 100, no. 1, pp. 8-13. https://doi.org/10.1016/j.ygyno.2005.08.016
Gupta, Naren ; Prasad, Puttur D ; Ghamande, Sharad A ; Martin, Pamela Moore ; Herdman, Anne V. ; Martindale, Robert G. ; Podolsky, Robert ; Mager, Sela ; Ganapathy, Malliga E. ; Ganapathy, Vadivel. / Up-regulation of the amino acid transporter ATB0,+ (SLC6A14) in carcinoma of the cervix. In: Gynecologic Oncology. 2006 ; Vol. 100, No. 1. pp. 8-13.
@article{540ba095a29a4d628abe6ed3cb9e78e1,
title = "Up-regulation of the amino acid transporter ATB0,+ (SLC6A14) in carcinoma of the cervix",
abstract = "Objective. ATB0,+ is an energy-coupled transporter for arginine and amino acid-based prodrugs. The objective of the study was to examine the expression of this transporter in cervical cancer. Methods. Specimens of normal ectocervical mucosa and cervical squamous cell carcinoma were used for determination of ATB0,+ mRNA levels by RT-PCR. A commercial dot blot of paired normal cervix and cervical cancer cDNA was also used to quantify ATB0,+ mRNA. ATB0,+ mRNA and protein in tissue sections were analyzed by in situ hybridization and immunohistochemistry/ immunofluorescence. Results. ATB0,+ mRNA increased 5.6-fold (P < 0.0004) in cervical cancer compared to normal cervix. This was associated with a parallel increase in ATB0,+ protein. Conclusions. Expression of ATB0,+ is minimal in normal cervix and is up-regulated in cervical cancer. The up-regulation of this highly concentrative transporter for arginine and prodrugs in cervical cancer has significant clinical and therapeutic relevance.",
keywords = "Amino acid transporter ATB, Arginine, Cervical cancer, Metastasis, Nitric oxide, Squamous cell carcinoma",
author = "Naren Gupta and Prasad, {Puttur D} and Ghamande, {Sharad A} and Martin, {Pamela Moore} and Herdman, {Anne V.} and Martindale, {Robert G.} and Robert Podolsky and Sela Mager and Ganapathy, {Malliga E.} and Vadivel Ganapathy",
year = "2006",
month = "1",
day = "1",
doi = "10.1016/j.ygyno.2005.08.016",
language = "English (US)",
volume = "100",
pages = "8--13",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Up-regulation of the amino acid transporter ATB0,+ (SLC6A14) in carcinoma of the cervix

AU - Gupta, Naren

AU - Prasad, Puttur D

AU - Ghamande, Sharad A

AU - Martin, Pamela Moore

AU - Herdman, Anne V.

AU - Martindale, Robert G.

AU - Podolsky, Robert

AU - Mager, Sela

AU - Ganapathy, Malliga E.

AU - Ganapathy, Vadivel

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Objective. ATB0,+ is an energy-coupled transporter for arginine and amino acid-based prodrugs. The objective of the study was to examine the expression of this transporter in cervical cancer. Methods. Specimens of normal ectocervical mucosa and cervical squamous cell carcinoma were used for determination of ATB0,+ mRNA levels by RT-PCR. A commercial dot blot of paired normal cervix and cervical cancer cDNA was also used to quantify ATB0,+ mRNA. ATB0,+ mRNA and protein in tissue sections were analyzed by in situ hybridization and immunohistochemistry/ immunofluorescence. Results. ATB0,+ mRNA increased 5.6-fold (P < 0.0004) in cervical cancer compared to normal cervix. This was associated with a parallel increase in ATB0,+ protein. Conclusions. Expression of ATB0,+ is minimal in normal cervix and is up-regulated in cervical cancer. The up-regulation of this highly concentrative transporter for arginine and prodrugs in cervical cancer has significant clinical and therapeutic relevance.

AB - Objective. ATB0,+ is an energy-coupled transporter for arginine and amino acid-based prodrugs. The objective of the study was to examine the expression of this transporter in cervical cancer. Methods. Specimens of normal ectocervical mucosa and cervical squamous cell carcinoma were used for determination of ATB0,+ mRNA levels by RT-PCR. A commercial dot blot of paired normal cervix and cervical cancer cDNA was also used to quantify ATB0,+ mRNA. ATB0,+ mRNA and protein in tissue sections were analyzed by in situ hybridization and immunohistochemistry/ immunofluorescence. Results. ATB0,+ mRNA increased 5.6-fold (P < 0.0004) in cervical cancer compared to normal cervix. This was associated with a parallel increase in ATB0,+ protein. Conclusions. Expression of ATB0,+ is minimal in normal cervix and is up-regulated in cervical cancer. The up-regulation of this highly concentrative transporter for arginine and prodrugs in cervical cancer has significant clinical and therapeutic relevance.

KW - Amino acid transporter ATB

KW - Arginine

KW - Cervical cancer

KW - Metastasis

KW - Nitric oxide

KW - Squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=29144507276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29144507276&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2005.08.016

DO - 10.1016/j.ygyno.2005.08.016

M3 - Article

VL - 100

SP - 8

EP - 13

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -